Robert Webster to Keynote at Influenza Meeting on July 9-11, 2014, in Boston, MA

Boston, MA (PressExposure) May 09, 2014 -- Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, Department of Infectious Diseases at St. Jude Children's Research Hospital to give a keynote presentation on "The Continued Threat of H5N1, H7N9 and H9N2 Influenza Viruses to a One World System" at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA, by GTCBio.

Dr. Webster is a Member of the Division of Virology; Department of Infectious Diseases at St. Jude Children's Research Hospital and holds the Rose Marie Thomas Chair. His interests include the emergence and control of influenza viruses, viral immunology, the structure and function of influenza virus proteins and the development of new vaccines and antivirals. Together with Graeme Laver he developed one of the first subunit vaccines for influenza that is still being produced in Australia. The major focus of his research is the importance of influenza viruses in wild aquatic birds as a major reservoir of influenza viruses and their role in the evolution of new pandemic strains for humans and lower animals. He contributed to the establishment of the Center of Excellence for Influenza Research at the University of Hong Kong and to the Center of Excellent for Influenza Research and Surveillance at St Jude Children's Research Hospital and to our understanding of the continuing evolution and control of novel influenza viruses. His curriculum vita contains over 650 original articles and reviews on influenza viruses with pandemic potential. He has trained many scientists who now contribute to our understanding of the evolution and pathogenesis of influenza and to vaccine development.

GTCBio's 3rd Annual Influenza Research and Development Conference will bring together experts from industry, government and academia to discuss the issues facing the influenza field. Topics will range from basic science of the influenza virus itself to pandemic preparedness to vaccination and clinical development. Attend this conference to learn, discuss and network with fellow scientists and researchers involved in various sectors of the influenza filed in an intimate setting.

This conference is also part of the Infectious Diseases World Summit 2014, which consists of this conference and two other conferences:
1) 12th Vaccines Research & Development: All Things Considered Conference
2) 11th Anti-Infectives Partnering and Deal-Making Conference

For more information, please visit

About GTCbio

GTCBio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

Global Technology Community (GTCBio), LLC, is a privately-held company founded in 2002.

Press Release Source:

Press Release Submitted On: May 09, 2014 at 1:56 am
This article has been viewed 55911 time(s).